Semaglutide 2mg/1.5mL Injection

Product Introduction

Semaglutide 2mg/1.5mL Injection is an injectable GLP-1 receptor agonist used for adults with type 2 diabetes when semaglutide injection is prescribed. It is given subcutaneously on the prescribed schedule and is not insulin. It should not be used for type 1 diabetes or diabetic ketoacidosis. Semaglutide increases glucose-dependent insulin release, lowers glucagon, slows gastric emptying, and can reduce appetite.

How to use

Inject Semaglutide 2mg/1.5mL Injection subcutaneously exactly as trained, using the prescribed schedule and dose. Rotate injection sites, follow storage instructions, and never share pens or needles.

How it works

Semaglutide activates GLP-1 receptors, increasing glucose-dependent insulin release, lowering glucagon, slowing gastric emptying, and reducing appetite.

Common side effects

Possible effects include nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, burping, reduced appetite, and injection-site reactions. Serious concerns include pancreatitis, gallbladder disease, kidney injury from dehydration, severe allergy, retinopathy worsening, and hypoglycemia with insulin or sulfonylureas.

Important information

Review type 1 diabetes, ketoacidosis, pancreatitis, gallbladder disease, kidney disease, severe GI disease, diabetic retinopathy, pregnancy plans, breastfeeding, insulin, sulfonylureas, thyroid cancer history, MEN2, and injection technique.